AAAAAA

   
Results: 1-13 |
Results: 13
ASPIRIN - BENEFIT AND RISK IN THROMBOPROPHYLAXIS
Authors: DICKINSON JP PRENTICE CRM
Citation: Jp. Dickinson et Crm. Prentice, ASPIRIN - BENEFIT AND RISK IN THROMBOPROPHYLAXIS, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(8), 1998, pp. 523-538
TRANSIENT ISCHEMIC ATTACKS
Authors: PRENTICE CRM
Citation: Crm. Prentice, TRANSIENT ISCHEMIC ATTACKS, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(11), 1998, pp. 787-787
VON-WILLEBRAND-FACTOR AND RISK OF ISCHEMIC STROKE
Authors: QIZILBASH N DUFFY S PRENTICE CRM BOOTHBY M WARLOW C
Citation: N. Qizilbash et al., VON-WILLEBRAND-FACTOR AND RISK OF ISCHEMIC STROKE, Neurology, 49(6), 1997, pp. 1552-1556
THE EFFECT OF DIFFERENT MICROTITRE PLATES ON THE ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) FOR ANTICARDIOLIPIN ANTIBODIES (ACAS) (VOL 84, PG 217, 1996)
Authors: HUGHES JR DAVIES JA PRENTICE CRM
Citation: Jr. Hughes et al., THE EFFECT OF DIFFERENT MICROTITRE PLATES ON THE ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) FOR ANTICARDIOLIPIN ANTIBODIES (ACAS) (VOL 84, PG 217, 1996), Thrombosis research, 84(6), 1996, pp. 481-481
THE EFFECT OF DIFFERENT MICROTITRE PLATES ON THE ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) FOR ANTICARDIOLIPIN ANTIBODIES (ACAS)
Authors: HUGHES JR DAVIES JA PRENTICE CRM
Citation: Jr. Hughes et al., THE EFFECT OF DIFFERENT MICROTITRE PLATES ON THE ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) FOR ANTICARDIOLIPIN ANTIBODIES (ACAS), Thrombosis research, 84(3), 1996, pp. 217-222
IS ASPIRIN SAFE FOR PATIENTS WITH HEART-FAILURE
Authors: CLELAND JGF BULPITT CJ FALK RH FINDLAY IN OAKLEY CM MURRAY G POOLEWILSON PA PRENTICE CRM SUTTON GC
Citation: Jgf. Cleland et al., IS ASPIRIN SAFE FOR PATIENTS WITH HEART-FAILURE, British Heart Journal, 74(3), 1995, pp. 215-219
A COMPARATIVE TRIAL OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) VERSUS STANDARD HEPARIN FOR THE PROPHYLAXIS OF POSTOPERATIVE DEEP-VEIN THROMBOSIS IN GENERAL-SURGERY
Authors: NURMOHAMED MT VERHAEGHE R HAAS S IRIARTE JA VOGEL G VANRIJ AM PRENTICE CRM TENCATE JW MARTIN I JOHNSTON D HUBENS A LAMY M DEBELLEVAUX J SCHULLMAN C VANDERMEER J WOOLTHUIS GMH HENKENS CMA LAMMES FB KETTING BW VANDERHEYDE MN BRUMMELKAMP WH PETTIGREW R PARRY B OAKLEY M SANDERSON K MONASTERIO J ROCHA E LASIERRA J NAVARRO JL BUCHHOLZ J WEISER HF WEBER HG HUSEMANN B WITTE J
Citation: Mt. Nurmohamed et al., A COMPARATIVE TRIAL OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) VERSUS STANDARD HEPARIN FOR THE PROPHYLAXIS OF POSTOPERATIVE DEEP-VEIN THROMBOSIS IN GENERAL-SURGERY, The American journal of surgery, 169(6), 1995, pp. 567-571
RELATION BETWEEN STABILITY OF REPERFUSION AND ACTIVATION OF HEMOSTATIC MECHANISMS FOLLOWING STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION
Authors: MORRIS JL ZAMAN AG ORCHARD MA COWAN JC PRENTICE CRM DAVIES JA
Citation: Jl. Morris et al., RELATION BETWEEN STABILITY OF REPERFUSION AND ACTIVATION OF HEMOSTATIC MECHANISMS FOLLOWING STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 1994, pp. 10000245-10000245
CARDIOGENIC THROMBOEMBOLISM - REVIEW OF CLINICAL-TRIALS
Authors: PRENTICE CRM
Citation: Crm. Prentice, CARDIOGENIC THROMBOEMBOLISM - REVIEW OF CLINICAL-TRIALS, Platelets, 4, 1993, pp. 9-11
APROTININ REDUCES CARDIOPULMONARY BYPASS-INDUCED BLOOD-LOSS AND INHIBITS FIBRINOLYSIS WITHOUT INFLUENCING PLATELETS
Authors: ORCHARD MA GOODCHILD CS PRENTICE CRM DAVIES JA BENOIT SE CREIGHTONKEMSFORD LJ GAFFNEY PJ MICHELSON AD
Citation: Ma. Orchard et al., APROTININ REDUCES CARDIOPULMONARY BYPASS-INDUCED BLOOD-LOSS AND INHIBITS FIBRINOLYSIS WITHOUT INFLUENCING PLATELETS, Thrombosis and haemostasis, 69(6), 1993, pp. 936-936
APOLIPOPROTEINS, FIBRINOGEN AND VON-WILLEBRAND-FACTOR AS RISK-FACTORSFOR ISCHEMIC STROKE
Authors: QIZILBASH N PRENTICE CRM DUFFY S DURRINGTON P WARLOW C
Citation: N. Qizilbash et al., APOLIPOPROTEINS, FIBRINOGEN AND VON-WILLEBRAND-FACTOR AS RISK-FACTORSFOR ISCHEMIC STROKE, Thrombosis and haemostasis, 69(6), 1993, pp. 1206-1206
APROTININ REDUCES CARDIOPULMONARY BYPASS-INDUCED BLOOD-LOSS AND INHIBITS FIBRINOLYSIS WITHOUT INFLUENCING PLATELETS
Authors: ORCHARD MA GOODCHILD CS PRENTICE CRM DAVIES JA BENOIT SE CREIGHTONKEMSFORD LJ GAFFNEY PJ MICHELSON AD
Citation: Ma. Orchard et al., APROTININ REDUCES CARDIOPULMONARY BYPASS-INDUCED BLOOD-LOSS AND INHIBITS FIBRINOLYSIS WITHOUT INFLUENCING PLATELETS, British Journal of Haematology, 85(3), 1993, pp. 533-541
ANTITHROMBOTIC THERAPY IN THE SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION
Authors: PRENTICE CRM
Citation: Crm. Prentice, ANTITHROMBOTIC THERAPY IN THE SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION, The American journal of cardiology, 72(19), 1993, pp. 70000175-70000180
Risultati: 1-13 |